Segall Bryant & Hamill LLC Acquires Shares of 240,415 Enhabit, Inc. $EHAB

Segall Bryant & Hamill LLC bought a new stake in Enhabit, Inc. (NYSE:EHAB) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 240,415 shares of the company’s stock, valued at approximately $1,926,000.

Several other institutional investors have also recently made changes to their positions in the company. Osaic Holdings Inc. boosted its stake in shares of Enhabit by 337.5% during the 2nd quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock worth $25,000 after purchasing an additional 2,018 shares during the period. State of Alaska Department of Revenue purchased a new stake in Enhabit in the 3rd quarter worth about $27,000. Tower Research Capital LLC TRC lifted its stake in Enhabit by 82.9% in the second quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock worth $44,000 after purchasing an additional 2,059 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in Enhabit by 523.1% in the second quarter. Russell Investments Group Ltd. now owns 5,795 shares of the company’s stock worth $56,000 after purchasing an additional 4,865 shares during the last quarter. Finally, Jones Financial Companies Lllp boosted its position in shares of Enhabit by 110,987.5% during the first quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock valued at $78,000 after buying an additional 8,879 shares during the period.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Citigroup reiterated a “buy” rating on shares of Enhabit in a report on Tuesday, December 16th. Weiss Ratings restated a “sell (e+)” rating on shares of Enhabit in a research note on Monday, December 29th. Deutsche Bank Aktiengesellschaft raised shares of Enhabit to a “buy” rating in a research report on Tuesday, January 13th. TD Cowen reiterated a “hold” rating and issued a $13.80 price target (up from $12.00) on shares of Enhabit in a report on Friday. Finally, Jefferies Financial Group downgraded Enhabit from a “buy” rating to a “hold” rating and raised their price objective for the stock from $12.50 to $13.80 in a report on Monday, February 23rd. Two investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $13.57.

Enhabit Stock Performance

Shares of Enhabit stock opened at $13.62 on Friday. Enhabit, Inc. has a one year low of $6.47 and a one year high of $13.64. The company has a 50-day simple moving average of $11.13 and a two-hundred day simple moving average of $9.37. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.58 and a current ratio of 1.63. The company has a market capitalization of $689.31 million, a PE ratio of -151.33 and a beta of 1.56.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, March 4th. The company reported $0.14 EPS for the quarter, meeting the consensus estimate of $0.14. The firm had revenue of $270.40 million during the quarter, compared to analyst estimates of $270.56 million. Enhabit had a positive return on equity of 4.71% and a negative net margin of 0.43%. Research analysts expect that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.